Key Takeaways
- Record revenue, guidance raised: Firstsource clocked its highest quarterly revenue ever and lifted FY25 constant-currency growth guidance to 11.5%–13.5% (from 10%–13%), driven by broad-based performance and three large deal wins.
- Margins held steady through investment: EBIT margin was 11%, flat QoQ and within the guided band, even as the company front-loaded investments in sales, solutions, and leadership hires.
- Healthcare and BFS drove the beat: The Healthcare vertical surged on payer transformation demand, while BFS countered its seasonally muted quarter through market-share gains in cost-optimization programs.
- The offshore shift is a deliberate margin lever: Offshore mix improved to 35% from 25% a year ago, a secular trend management is using to fund investments before letting the benefit flow to reported margins starting next year.
- What to watch next quarter: Whether the Q2 wage revision headwind is absorbed within the 11%–12% margin band, the pace of ramp-up on the three large deals, and any recovery in the Diverse vertical.
Revenue Performance & Vertical Trends
- BFS countered seasonality: The vertical grew despite a historically muted Q1, helped by concentrated efforts to reduce macro dependency; elevated interest rates remain an overhang in mortgages, but cost-optimization programs are expanding market share and new sales hires are opening access to large logos.
- Healthcare surged on payer pressure: Medicare utilization is rising in the US, and weaker payment rates plus high medical costs are squeezing insurer margins, triggering a surge in transformative initiatives; the QBSS acquisition integration completed during Q1 and already delivered its first joint deal win plus two additional transactions.
- CMT built pipeline across sub-verticals: Telecom and media showed healthy momentum, the EdTech engagement with ETS is scaling, and the company is working with two of the largest Consumer Tech brands on AI model training; management expects logo conversions in the coming quarter.
- Diverse declined on one account: Revenues fell 3% QoQ due to seasonally lower volumes in a single large account, with recovery expected in Q2.
- US broad-based, Europe volatile: US growth was driven by broad-based performance; Europe declined on quarterly volatility in a couple of clients and the optical impact of an onshore-to-offshore shift in a top client; UK cost pressures are increasing carve-out deal conversations and offshoring interest.
Ritesh Idnani: "Medicare utilization has been on the rise in the US and along with weaker payment rates and high medical costs, this is putting pressure on the margins of healthcare insurers. This has led to a surge in transformative initiatives across our payer clients as they seek ways of optimizing their cost structures."
Deal Wins & Pipeline
- Three large deals in one quarter: A first for Firstsource, each with ACV above US$5 million, expected to ramp in phases over coming quarters; one from an existing Fortune 500 managed healthcare company for member and provider services and end-to-end claims processing, one expanding footprint in a top-five US healthcare insurer for digital intake and claims, and one new logo from a premier SaaS freight platform for customer service and back-office operations.
- UK pension administrator added: A new logo scale deal to improve service coverage.
- QBSS synergies already converting: The acquisition closed its first joint deal in Q1 and helped close two additional transactions in the provider RCM space, validating the acquisition rationale.
- Pipeline breadth supports guidance: BFS has several potentially large logos in pipeline; Healthcare has several potentially large deals across a large client base; CMT has a good deal pipeline including a couple of large deals in advanced stages.
Margins: Investment Phase, Offshore Lever
- Q1 margin held at 11%: Down 70 bps YoY but flat QoQ and within the guided 11%–12% band, despite stepped-up investments in three areas: sales and account teams (grown by roughly one-third in six months), capability building (leadership hires, solutions teams, relAI launch, trust and safety practice), and brand amplification.
- Q2 wage revision headwind: The annual wage revision cycle was advanced from Q3 to Q2, which will pressure Q2 margins, but management is confident of staying within the guided band for the full year.
- Offshore mix as a margin lever: The offshore-onshore mix improved from 25-75 to 35-65 over four quarters, a secular directional trend; offshore delivery carries higher margins, but near-term benefits are being reinvested into business-building rather than flowing to the bottom line.
- 24 margin levers identified: Beyond offshoring, levers include span-of-control optimization and consolidation of onsite delivery locations, with more visible impact expected over coming quarters; management is also taking a hard look at accounts with sub-optimal profitability and pushing for corrective steps including contract commercial reviews.
- Investment peak nearing: The bulk of initial investments on the people front is expected to be largely over by next quarter; cost optimization and margin improvement should gradually become visible over H2, with more visible flow-through in reported margins starting next year.
Ritesh Idnani: "I feel comfortable with our ability to drive a consistent improvement in our margins, which would have a more visible flow through in our reported margin starting next year, even as we keep them in a narrow band during our investment phase in the near term."
Strategic Initiatives & AI Positioning
- relAI suite launched: A suite of AI-led offerings, solutions and platforms covering the full lifecycle from discovery (AI readiness assessment, use case identification, platform selection) to mature-phase work (data engineering, AI platform stacks, LLM verification and training).
- AI infusion into existing platforms: Healthtech, Fintech and CX platforms are being infused with AI to enhance operational efficiencies.
- Collections as a Service launched: A digital collections capability allowing customers to build collections with minimal human intervention, configurable from the start.
- GenAI view is pragmatic: Management sees many POCs still being executed with very little moving into production; AI will cannibalize some lower-end BPS services but not materially, while new business opportunities using AI (data, AI/ML ops, tech-led trust and safety) are far bigger.
- Customer Advisory Board established: Composed of experts across financial services, healthcare, communications, media and technology verticals.
Ritesh Idnani: "What I do expect is that AI will certainly cannibalize some of the lower end of the BPS services but it's not material enough. New business opportunities using AI is far bigger..."
Balance Sheet & Operations
- DSO spiked then normalized: DSO moved up to 68 days due to delayed collection on a couple of healthcare accounts; almost all were collected in the first two weeks of July, normalizing to 61 days.
- Debt restructuring for cost arbitrage: Some short-term working capital loans were converted to long-term for interest cost arbitrage.
- Net debt reduction path: Surplus cash of $10–$12 million per quarter is expected to be used to repay borrowings; net debt zero is likely within 6–8 quarters.
- Attrition trending down: Trailing 12-month attrition fell to 32% from 35.4% in Q4FY24 and 41.7% in Q1FY24, expected to continue declining at a more moderate pace.
- Sourcepoint acquisition closed out: The final installment of US$2.5 million was paid in April 2024; all payments are now complete.
- Capacity added: Two new seating facilities added in Chennai and the Philippines.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Revenue growth | 11.5%–13.5% constant currency (raised from 10%–13%) | FY25 |
| EBIT margin | 11%–12%, inclusive of upfront investments | FY25 |
| Margin improvement trajectory | 50–75 bps improvement each year | Medium-term, starting next fiscal |
| Long-term margin aspiration | Converge to 14%–15% EBIT margin | Next 3–4 years |
| Revenue run rate | US$1 billion | Q4 FY26 |
| Net debt | Net debt zero | 6–8 quarters |
| Investment phase peak | Bulk of initial people investments largely over | Next quarter |
| Diverse vertical | Recovery from Q1 seasonal decline | Q2 FY25 |
| Tax rate | 18%–20% | FY25 |
Key Metrics
| Metric | Q1 FY25 |
|---|---|
| Revenue | ₹1,790 cr, +17.1% YoY |
| Revenue (USD) | $215 million, +15.4% YoY and +6.7% QoQ |
| Constant currency revenue growth | 6.5% QoQ, 14.8% YoY |
| Operating profit (EBIT) | ₹197 cr, +10% YoY |
| EBIT margin | 11%, down 70 bps YoY, flat QoQ, within guided 11%–12% band |
| Net profit | ₹135 cr, 7.6% of revenue |
| Diluted EPS | ₹1.92 |
| Tax rate | 19.1%, within guided 18%–20% range for FY25 |
| Revenue growth guidance (FY25, constant currency) | 11.5% to 13.5%, raised from initial 10% to 13% |
| EBIT margin guidance (FY25) | 11% to 12%, maintained |
| Large deals signed | 3, with ACV over US$5 million each |
| New logos added | 10 |
| Trailing 12-month attrition | 32%, improved from 35.4% in Q4FY24 and 41.7% in Q1FY24 |
| Employee count | 29,231 as of 30th June 2024 |
| Offshore-onshore revenue mix | 35-65, improved from 25-75 in Q1 FY24 |
| Reported DSO | 68 days, normalized to 61 days after early-July collections |
| Net debt | ~$110–$115 million, expected to reach zero in 6–8 quarters |